Menu
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 65,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care.
1 Becton Dr
Franklin Lakes, New Jersey 07417-1815
Phone: 12018476800
www.bd.com
Madison Investments, an investment advisor, released its “Madison Investors Fund” first-quarter 2024 investor letter. A copy of the same can be downloaded here. In the first quarter, the fund (Class Y) returned 9.63% compared to a 10.56% return for the S&P 500 index. The business remains dedicated to its more than two-decades-old strategy of investing in […]
WASHINGTON (dpa-AFX) - Medical technology company BD or Becton, Dickinson and Co. (BDX) announced Friday the global commercial release of new cell sorters that will enable more researchers in a br…
https://www.investing.com/news/company-news/citi-maintains-neutral-on-becton-dickinson-with-260-target-93CH-3366334
Looking for Dividend aristocrats trading at their 52-week lows? If so, you’ve come to the right place. Investing shouldn’t always be about chasing high-flying stocks. Sometimes, the best picks can be those hiding in plain sight. A contrarian view might give you a once-in-a-decade opportunity to own a top-tier stock. I can’t blame investors for rushing to the exit when stocks are in free fall. However, prudent investors know that downturns can be great opportunities to snag quality stocks at a bargain. Dividend Aristocrats trading around their 52-week lows can be a good starting point. These companies have proven they can weather economic downturns with their steady income, stable business models, and strong foundations. So, lower prices, high dividend payouts, and reliable increases equal great growth potential over the long term. Picking the right ones could offer you some of the best long-term returns that last until retirement. The 52-week low, meanwhile, offers investors a snapshot of the stock’s current support base – where other investors may flock to snap up shares at a discount.
https://www.investing.com/news/stock-market-news/citi-sees-90day-upside-for-becton-dickinson-stock-amid-easing-headwinds-93CH-3363280
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced that it has entered into a settlement agreement with Becton, Dickinson and Company (“BD”) to resolve all outstanding patent litigation with Jetzt den vollständigen Artikel lesen
Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against Becton, Dickinson and Company …
On CNBC’s "Mad Money Lightning Round," Jim Cramer sang the praises of Energy Transfer LP (NYSE: ET ), which posted better-than-expected earnings for its fourth quarter . Cramer also mentioned how KKR & Co. Inc. (NYSE: KKR ) and Blackstone (NYSE: BX ) are having "a big run now." "They’re very good, and I think they can make more money than they have," he added. KKR and Blackstone have over $550 billion and $1 trillion in assets under management, respectively. On March 26, Weave Living and KKR reported the establishment of a strategic partnership to invest in rental housing assets in South Korea. Rio Tinto Group (NYSE: RIO ) is a "great company to buy here," Cramer said. On Feb. 21, Rio Tinto reported full-year FY23 results. Sales revenue declined 3% Y/Y to $54 billion, beating the consensus of $53.9 billion. Underlying EPS decreased 12% Y/Y to $7.25, missing the street view of $7.27. The "Mad Money" host recommended buying Becton, Dickinson and Company (NYSE: BDX ). "The stock has been getting crushed," he noted.